pharmaceuticals-and-healthcare

United States Phenylketonuria (PKU) Market 2017


Published On : May 2017

Category : Pharmaceutical

No. of Pages : 131 pages

  • $3800
  • $7600

Please click below to avail discount on this report

In the last several years, United States market of Phenylketonuria (PKU) developed rapidly, with an average growth rate of 11%. In 2016, global revenue of Phenylketonuria (PKU) is nearly 438 M USD.

This report studies Phenylketonuria (PKU) in United States market, especially in Northeast, South Atlantic, West South Central, East North Central, Pacific, focuses on top manufacturers in United States market, with sales, price, revenue and market share for each manufacturer, covering
Biomarin
Vitaflo
Mead Johnson
Nutricia
Cambrooke
Dr. Schar
Prominmetabolics
PKU Perspectives

Market Segment by Regions, this report splits United States into several key Regions, with revenue, sales, market share and growth rate of Phenylketonuria (PKU) in these regions, from 2012 to 2022 (forecast), like
Northeast
South Atlantic
West South Central
East North Central
Pacific
Other

Split by Product Types, with revenue, market share and growth rate of each type, can be divided into
Medications
Supplements
Others
Split by applications, this report focuses on consumption, market share and growth rate of Phenylketonuria (PKU) in each application, can be divided into
Household
Hospital
Others

In the recent times, the global market for United states phenylketonuria pku market 2017 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of United states phenylketonuria pku market 2017 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the United states phenylketonuria pku market 2017 production processes, which is also reflecting positively on the growth of this market.

The research report on the United states phenylketonuria pku market 2017 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of United states phenylketonuria pku market 2017 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for United states phenylketonuria pku market 2017, including the definition, classification, and industry chain structure of United states phenylketonuria pku market 2017, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the United states phenylketonuria pku market 2017.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for United states phenylketonuria pku market 2017 in details. It provides in-depth information on the development trends and the policies and regulations, concerning United states phenylketonuria pku market 2017, implemented in each of the geographical segments. The predominant applications of the United states phenylketonuria pku market 2017 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for United states phenylketonuria pku market 2017 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the United states phenylketonuria pku market 2017 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Picture of Phenylketonuria (PKU)1
Figure Medications for Phenylketonuria (PKU)2
Table Classification of Phenylketonuria (PKU) by Product Category2
Figure United States Phenylketonuria (PKU) Revenue Market Share by Types (Product Category) in 20163
Figure Medications Product Picture3
Figure Supplements Product Picture4
Table Applications of Phenylketonuria (PKU)4
Figure United States Revenue Market Share of Phenylketonuria (PKU) by Applications in 20165
Figure United States Phenylketonuria (PKU) Market Size (M USD) Comparison by Regions (2012-2022)6
Figure Northeast Phenylketonuria (PKU) Revenue (M USD) and Growth Rate (2012-2022)7
Figure South Atlantic Phenylketonuria (PKU) Revenue (M USD) and Growth Rate (2012-2022)8
Figure West South Central Phenylketonuria (PKU) Revenue (M USD) and Growth Rate (2012-2022)9
Figure East North Central Phenylketonuria (PKU) Revenue (M USD) and Growth Rate (2012-2022)10
Figure Pacific of US Phenylketonuria (PKU) Revenue (M USD) and Growth Rate (2012-2022)11
Figure Other Phenylketonuria (PKU) Revenue (M USD) and Growth Rate (2012-2022)12
Figure United States Phenylketonuria (PKU) Sales (K Unit) and Growth Rate (2012-2022)13
Figure United States Phenylketonuria (PKU) Revenue (M USD) and Growth Rate (2012-2022)14
Table United States Phenylketonuria (PKU) Sales (K Unit) of Key Players/Manufacturers (2012-2017)15
Table United States Phenylketonuria (PKU) Sales Share by Players/Manufacturers (2012-2017)15
Figure 2016 United States Phenylketonuria (PKU) Sales Share by Players/Manufacturers16
Figure 2017 United States Phenylketonuria (PKU) Sales Share by Players/Manufacturers17
Table United States Phenylketonuria (PKU) Revenue (M USD) by Players/Manufacturers (2012-2017)17
Table United States Phenylketonuria (PKU) Revenue Market Share by Players/Manufacturers (2012-2017)18
Figure 2016 United States Phenylketonuria (PKU) Revenue Market Share by Players/Manufacturers19
Figure 2017 United States Phenylketonuria (PKU) Revenue Market Share by Players/Manufacturers20
Table United States Market Phenylketonuria (PKU) Average Price (USD/Unit) of Key Players/Manufacturers (2012-2017)20
Figure United States Market Phenylketonuria (PKU) Average Price (USD/Unit) of Key Players/Manufacturers in 201621
Figure 2016 United States Phenylketonuria (PKU) Revenue Market Share by Players/Manufacturers22
Figure United States Phenylketonuria (PKU) Revenue Market Share of Top 3 Players/Manufacturers in 201623
Figure United States Phenylketonuria (PKU) Revenue Market Share of Top 5 Players/Manufacturers in 201623
Table Mergers & Acquisitions, Expansion Analysis24
Table United States Players/Manufacturers Phenylketonuria (PKU) Headquarters and Sales Area27
Table United States Players/Manufacturers Phenylketonuria (PKU) Product Category28
Table United States Phenylketonuria (PKU) Sales (K Unit) by Regions (2012-2017)29
Table United States Phenylketonuria (PKU) Sales Share by Regions (2012-2017)29
Figure United States Phenylketonuria (PKU) Sales Share by Regions (2012-2017)30
Figure United States Phenylketonuria (PKU) Sales Market Share by Regions in 201630
Table United States Phenylketonuria (PKU) Revenue (M USD) and Market Share by Regions (2012-2017)31
Table United States Phenylketonuria (PKU) Revenue Market Share by Regions (2012-2017)31
Figure United States Phenylketonuria (PKU) Revenue Market Share by Regions (2012-2017)32
Figure United States Phenylketonuria (PKU) Revenue Market Share by Regions in 201632
Table United States Phenylketonuria (PKU) Price (USD/Unit) by Regions (2012-2017)33
Table United States Phenylketonuria (PKU) Sales (K Unit) by Type (2012-2017)34
Table United States Phenylketonuria (PKU) Sales Share by Type (2012-2017)34
Figure United States Phenylketonuria (PKU) Sales Share by Type (2012-2017)35
Figure United States Phenylketonuria (PKU) Sales Market Share by Type in 201635
Table United States Phenylketonuria (PKU) Revenue (M USD) by Type (2012-2017)36
Table United States Phenylketonuria (PKU) Revenue Market Share by Type (2012-2017)36
Figure Revenue Market Share of Phenylketonuria (PKU) by Type (2012-2017)36
Figure Revenue Market Share of Phenylketonuria (PKU) by Type in 201637
Table United States Phenylketonuria (PKU) Price (USD/Unit) by Types (2012-2017)37
Figure United States Phenylketonuria (PKU) Revenue Growth Rate by Type (2012-2017)38
Table United States Phenylketonuria (PKU) Revenue (M USD) by Applications (2012-2017)39
Table United States Phenylketonuria (PKU) Revenue Market Share by Applications (2012-2017)39
Figure United States Phenylketonuria (PKU) Revenue Market Share by Applications (2012-2017)40
Figure United States Phenylketonuria (PKU) Revenue Market Share by Applications in 201640
Table United States Phenylketonuria (PKU) Revenue Growth Rate by Applications (2012-2017)41
Figure United States Phenylketonuria (PKU) Revenue Growth Rate by Applications (2012-2017)41
Table Biomarin Company Profile42
Table Phenylketonuria (PKU) Product Information of Biomarin43
Table Phenylketonuria (PKU) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Biomarin 2012-201744
Figure Phenylketonuria (PKU) Revenue (M USD) and Growth Rate of Biomarin 2012-201745
Figure Phenylketonuria (PKU) Revenue (M USD) and Global Market Share of Biomarin 2012-201745
Table Vitaflo Company Profile46
Table Phenylketonuria (PKU) Product Information of Vitaflo47
Table Phenylketonuria (PKU) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Vitaflo 2012-201748
Figure Phenylketonuria (PKU) Revenue (M USD) and Growth Rate of Vitaflo 2012-201749
Figure Phenylketonuria (PKU) Revenue (M USD) and Global Market Share of Vitaflo 2012-201749
Table Mead Johnson Company Profile50
Table Phenylketonuria (PKU) Product Information of Mead Johnson51
Table Phenylketonuria (PKU) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Mead Johnson 2012-201752
Figure Phenylketonuria (PKU) Revenue (M USD) and Growth Rate of Mead Johnson 2012-201752
Figure Phenylketonuria (PKU) Revenue (M USD) and Global Market Share of Mead Johnson 2012-201753
Table Nutricia Company Profile53
Table Phenylketonuria (PKU) Product Information of Nutricia55
Table Phenylketonuria (PKU) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Nutricia 2012-201757
Figure Phenylketonuria (PKU) Revenue (M USD) and Growth Rate of Nutricia 2012-201758
Figure Phenylketonuria (PKU) Revenue (M USD) and Global Market Share of Nutricia 2012-201758
Table Cambrooke Company Profile59
Table Phenylketonuria (PKU) Product Information of Cambrooke60
Table Phenylketonuria (PKU) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Cambrooke 2012-201761
Figure Phenylketonuria (PKU) Revenue (M USD) and Growth Rate of Cambrooke 2012-201762
Figure Phenylketonuria (PKU) Revenue (M USD) and Global Market Share of Cambrooke 2012-201762
Table Dr. Schar Company Profile63
Table Phenylketonuria (PKU) Product Information of Dr. Schar64
Table Phenylketonuria (PKU) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Dr. Schar 2012-201764
Figure Phenylketonuria (PKU) Revenue (M USD) and Growth Rate of Dr. Schar 2012-201765
Figure Phenylketonuria (PKU) Revenue (M USD) and Global Market Share of Dr. Schar 2012-201766
Table Prominmetabolics Company Profile66
Table Phenylketonuria (PKU) Product Information of Prominmetabolics67
Table Phenylketonuria (PKU) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Prominmetabolics 2012-201768
Figure Phenylketonuria (PKU) Revenue (M USD) and Growth Rate of Prominmetabolics 2012-201768
Figure Phenylketonuria (PKU) Revenue (M USD) and Global Market Share of Prominmetabolics 2012-201769
Table PKU Perspectives Company Profile69
Figure Phenylketonuria (PKU) Product Information of PKU Perspectives70
Table Phenylketonuria (PKU) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of PKU Perspectives 2012-201771
Figure Phenylketonuria (PKU) Revenue (M USD) and Growth Rate of PKU Perspectives 2012-201771
Figure Phenylketonuria (PKU) Revenue (M USD) and Global Market Share of PKU Perspectives 2012-201772
Figure Typical Phases from Research to Market for a Drug Candidate74
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound75
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound76
Figure Manufacturing Cost Structure of Phenylketonuria (PKU)76
Figure 2016 USA Labor Cost Index Point Analysis77
Figure 2012-2016 USA Labor Cost Index Point Analysis77
Figure 2016 USA Average Hourly Wages (USD/H)78
Figure 2012-2016 USA Average Hourly Wages (USD/H)78
Figure Cost of Employing a Factory Worker80
Table Average Price of Electricity to Ultimate Customers 2007-201681
Figure Manufacturing Process Analysis of Phenylketonuria (PKU)83
Figure Phenylketonuria (PKU) Industrial Chain Analysis84
Table Major Buyers of Phenylketonuria (PKU)85
Figure Marketing Channel for Biopharmaceuticals88
Table Distributors/Traders List94
Table Observed Blood Phe Concentration at Treatment Naive Baseline, Start and End of RDT (mITT Population)95
Table Summary of Secondary Efficacy Endpoints in RDT and Efficacy Endpoints in Exploratory Sub Study of Cognitive Function96
Table Change in ADHD-RS Inattention in PRISM 1 and PRISM 2 Part 1 in Subjects with Naive Baseline Inattention >997
Table Correlation of Change from Naive Baseline to Open Label Extension at Week 41 between Blood Phe Concentration and ADHD Inattention Subscale Score in PRISM 298
Figure Global GDP Growth Rate for 2015101
Figure USA GDP (Billion USD) Change 2006-2016102
Figure USA GDP Annual Growth Rate 2012-2016102
Figure USA Consumer Price Index (CPI) 2016-2017103
Figure United States Phenylketonuria (PKU) Sales (K Unit) and Growth Rate Forecast (2017-2022)104
Figure United States Phenylketonuria (PKU) Revenue (M USD) and Growth Rate Forecast (2017-2022)105
Figure United States Phenylketonuria (PKU) Price (USD/Unit) Trend Forecast (2017-2022)105
Table United States Phenylketonuria (PKU) Revenue (M USD) Forecast by Type (2017-2022)106
Figure United States Phenylketonuria (PKU) Revenue (M USD) Forecast by Type (2017-2022)106
Figure United States Phenylketonuria (PKU) Revenue (M USD) Market Share Forecast by Type in 2022107
Table United States Phenylketonuria (PKU) Revenue (M USD) Forecast by Application (2017-2022)107
Figure United States Phenylketonuria (PKU) Revenue Market Share Forecast by Application (2017-2022)108
Figure United States Phenylketonuria (PKU) Revenue Market Share Forecast by Application in 2022108
Table United States Phenylketonuria (PKU) Revenue (M USD) Forecast by Regions (2017-2022)109
Table United States Phenylketonuria (PKU) Revenue Share Forecast by Regions (2017-2022)109
Figure United States Phenylketonuria (PKU) Revenue Share Forecast by Regions in 2022110
Table Research Programs/Design for This Report112
Figure Bottom-up and Top-down Approaches for This Report114
Figure Data Triangulation115
Table Key Data Information from Secondary Sources116
Table Key Data Information from Primary Sources117

Send an Enquiry

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top